Generally, when patients ask me about stem cell therapy for autoimmune diseases in Thailand i tend to first explain that Autoimmune disease is not just an “overactive immune system. This is a decompensated or out of balance immune system.
In autoimmune diseases, the body is unable to distinguish between its own tissues and foreign materials; under certain conditions it attacks itself. Depending on the diagnosis, this can impact many different parts of a body (the joints, skin, nerves and gut), or multiple organs at the same time.,e.g. thyroids/lungs/kidneys etc). Patients can have flares, fatigue, pain and stiffness all over the body with changes in nerves or energy levels.
Because of this, treatment should never be oversimplified to a single promise. Stem cell therapy is not a miracle cure, It must be interpreted as an assist supported regenerative cure plan that might aid “traficking” of immune signaling and inflammatory equilibrium in selected patients.
Immune Suppression vs. Immune Modulation
Most traditional autoimmunity therapies target some subsets of immune response. Steroids, immunosuppressive agents and biologic drugs can be invaluable when it comes to treatment – some times even life-changing. These could do include long-term implications such because as whether together with one a infection threat like medications, or ability intolerance worse in others.
However, stem cell therapy such as mesenchymal stem cell therapy is usually covered in a different way. That doesn’t mean to switch off the immune system. We are working towards immune modulation — inducing the communication and self-regulation of our own human system.
Mesenchymal stem cells (MSCs) have drawn particular interest because they are suspected to induce phenotypic and functional changes beyond simply cell-to-cell contact with innate or adaptive immune cells, using soluble factors released from their regenerative properties. MSCs stem cell therapy are described to carry out immunomodulation through cytokines, chemokines, extracellular vesicles (EVs) and other biological messages.
Figure 1: Conceptual Overview of Stem Cell Therapy for Autoimmune Diseases Through Immune Modulation and Inflammation Balance
The Potential Role of UC-MSCs in Autoimmunity
When it comes to autoimmune cases at Vega Medical Services, the discussion is typically around MSCs stem cell therapy; umbilical cord-derived mesenchymal stem cells. These cells never wind up being used, because they don’t just turn into the new organ or directly fix some tissue that was damaged.
Cellular signalling further clarifies their primary function.
MSCs stem cell therapy may secrete growth factors, cytokines, extracellular vesicles and microRNAs to modulate communication between the immune system and inflamed tissue environments. This communication may be relevant in autoimmune disease because often the body is on an ongoing immune activation continuum.
To illustrate this to the patients:
MSCs stem cell therapy would ostensibly promote a more quiescent, organized immune milieu.
It is not like the disease goes away in a day. That the treatment is not a single entity, but is part of an overall plan to help balance inflammation and regulation of our immune system communication for tissue repair.
Conditions Often Discussed
Patients have heard that stem cell therapy can treat them for autoimmune-related conditions; they ask about rheumatoid arthritis, lupus, multiple sclerosis, ulcerative colitis and Crohn’s disease psoriasis Hashimoto’s thyroiditis aor other chronic inflammatory disorders.
Each condition is different. A patient with quiescent autoimmune arthritis is not the same as a patient active lupus nephritis. That is, an inflammatory bowel disease patient only; but not a neurological autoimmune involvement line. This is precisely why a medical review should precede any chatter regarding dose, route, or timeline.
Why Thailand?
Because of its private healthcare infrastructure, medical tourism support, and access to physician-guided wellness & longevity programs. Thailand is now home for patients searching options in the field known as regenerative medicine. Many international patients also find stem cell therapy in Thailand relatively easy to access compared with some Western healthcare systems.
Patients are better off avoiding choosing a clinic based on price or marketing alone. Autoimmune disease is a clinical diagnosis made on suspicion and after careful medical judgement. Before finalising a plan, the clinic should review: Diagnosis; disease stage; current medications (steroids and other immunosuppressive therapy); recent flare history (major organ involvement with any functioning state or risk of infection due to prior treatments).
Dangers for Patients to Watch Out For
In patients with an active severe flare, control of infection status, severity and stability of organ function (safe to get back on the immunosuppressive drug), recent history of cancer treatment was assessed as well when contraindications were considered. These scenarios do not automatically mean a patient will be denied treatment, but they require an MD review and risk evaluation.
Patients should also refrain from underlying the prescribed autoimmune medicine without referring to their physician. In cases where standard care is necessary medically, stem cell therapy should not be a substitute.
Regulatory authorities warn about regenerative medicine clotting that outside cannot represent enough tissue to send. In autoimmune disease this is particularly useful as patients can have very differing immune profiles.
Final Thoughts
Autoimmune disease is a complicated illness, and it must be treated with an understanding of that complexity. The potential role that stem cell therapy may play in modulating immune processes, cellular signaling, and balancing inflammation means it should never be marketed as a cure but could certainly be considered when discussing adjunctive options for select patients.
For patients weighing this option, the key question is not whether stem cells treat autoimmune disease.